WHO ICTRP trial
Same as above
EUCTR2020-006003-42-DK · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2020-006003-42-DK |
|---|---|
| Public title | Same as above |
| Scientific title | National Cohort Study of Effectiveness and Safety of SARS-CoV-2/Covid-19 vaccines (ENFORCE) - ENFORCE |
| Primary sponsor | CHIP - Rigshospitalet - University of Copenhagen |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): yes |
| Countries | Denmark |
| Conditions | The aim is to study primarily effectiveness as well as safety of citizens being vaccinated with one of the SARS-CoV2 vaccines being applied in the Danish COVID-19 vaccine programme. Whereas ongoing phase III trials are reporting vaccine… |
| Interventions | Trade Name: COMIRNATY concentrate for dispersion for injection COVID-19 mRNA Vaccine (nucleoside modified) Pharmaceutical Form: Concentrate for solution for injection INN or Proposed INN: COMIRNATY Other descriptive name: COVID-19 mRNA… |
| Registration date | Dec 21, 2020 |
| Target size | 10000 |
| Secondary IDs | ENFORCE |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: